Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

NCT07284602 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1100

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis (IPF)

Interventions

DRUG: Deupirfenidone
DRUG: Pirfenidone (PFD)

Sponsor

PureTech